当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析 - 资产负债表

天康生物

(002100)

  

流通市值:104.44亿  总市值:104.44亿
流通股本:13.65亿   总股本:13.65亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金3,844,797,066.033,844,717,202.033,890,870,268.583,319,501,233.59
衍生金融资产6,742,55010,262,7608,729,27011,054,880
应收票据及应收账款817,994,674.76731,843,471.87738,306,532.85407,120,869.29
其中:应收票据16,458,703.8819,821,055.1115,899,611.7210,677,086.17
应收账款801,535,970.88712,022,416.76722,406,921.13396,443,783.12
应收款项融资---2,717,577.72
预付款项372,484,447.66397,308,739.18666,450,024.921,151,042,840.64
其他应收款合计351,370,983.81301,730,176.84308,355,507.29294,986,760.96
存货3,235,000,195.845,123,273,2756,783,848,235.266,039,231,841.92
其他流动资产333,624,092.1471,207,573.4593,933,497.75536,403,817.29
流动资产平衡项目0000
流动资产合计8,962,014,010.210,980,343,198.3212,990,493,336.6512,412,059,821.41
非流动资产:
长期股权投资38,837,542.0538,510,798.2421,357,276.88105,445,142.28
固定资产5,208,288,708.925,080,782,352.25,146,462,778.115,005,100,365.7
在建工程795,929,369.79836,875,324.47548,691,693.24553,581,056.92
生产性生物资产363,420,100.66363,076,431.92379,262,172.95359,004,790.46
使用权资产577,342,480.71558,376,403.05561,639,359.35542,713,962.09
无形资产337,173,141.32340,964,183.94273,301,484.87267,436,591.92
开发支出9,056,886.347,190,235.3612,982,627.277,705,622.64
商誉215,097,618.37215,097,618.37342,959,059.0622,242,295.89
长期待摊费用21,883,792.4221,652,667.0520,874,544.0623,076,349.06
递延所得税资产45,811,445.127,392,245.4943,060,894.8630,828,904.34
其他非流动资产41,930,735.941,917,626.4733,686,00031,800,000
非流动资产平衡项目0000
非流动资产合计7,654,771,821.587,531,835,886.567,384,277,890.656,948,935,081.3
资产平衡项目0000
资产总计16,616,785,831.7818,512,179,084.8820,374,771,227.319,360,994,902.71
流动负债:
短期借款1,104,603,346.662,653,600,0003,818,000,0003,214,300,998
衍生金融负债-51,400542,7605,325,750
应付票据及应付账款638,837,082.74546,257,969.4521,127,043.16626,849,041.2
其中:应付票据8,414,8004,218,800--
应付账款630,422,282.74542,039,169.4521,127,043.16626,849,041.2
预收款项---83,333.36
合同负债346,605,564.3736,355,940.57488,785,751.02473,827,870.81
应付职工薪酬243,628,143.89249,176,483.29311,594,261.32307,543,347.64
应交税费28,719,225.520,183,772.424,478,106.5617,121,566.87
其他应付款合计769,219,264.43760,799,298.28989,224,193.8695,862,898.25
应付股利-48,299,113.78-2,920,922.68
一年内到期的非流动负债2,274,712,195.481,525,875,485.381,083,465,140.78726,683,502.99
其他流动负债60,640,441.1780,196,266.3477,814,583.52106,116,605.72
流动负债平衡项目0000
流动负债合计5,466,965,264.176,572,496,615.667,315,031,840.166,173,714,914.84
非流动负债:
长期借款1,773,371,027.062,552,607,302.772,878,000,0003,133,000,000
租赁负债453,641,426.75372,967,090.84321,554,453.32302,534,524.48
递延收益109,169,570.6797,069,778.6390,059,222.7386,060,305.62
递延所得税负债16,550,962.49714,384.68714,384.68714,384.68
非流动负债平衡项目0000
非流动负债合计2,352,732,986.973,023,358,556.923,290,328,060.733,522,309,214.78
负债平衡项目0000
负债合计7,819,698,251.149,595,855,172.5810,605,359,900.899,696,024,129.62
所有者权益(或股东权益):
实收资本(或股本)1,355,019,3521,354,788,8571,354,581,0521,354,339,175
其他权益工具3,371,340.343,449,421.233,520,378.123,604,828.14
资本公积3,914,766,499.993,912,975,588.653,936,237,761.323,842,440,516.17
其他综合收益4,517,481.5522,522,514.6311,270,174.011,421,954.94
盈余公积439,075,429.82439,075,429.82439,075,429.82439,075,429.82
一般风险准备3,854,383.763,854,383.763,854,383.763,854,383.76
未分配利润1,433,596,431.851,490,689,901.842,290,848,706.522,305,130,958.28
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计7,154,200,919.317,227,356,096.938,039,387,885.557,949,867,246.11
少数股东权益1,642,886,661.331,688,967,815.371,730,023,440.861,715,103,526.98
股东权益平衡项目0000
股东权益合计8,797,087,580.648,916,323,912.39,769,411,326.419,664,970,773.09
负债和股东权益合计16,616,785,831.7818,512,179,084.8820,374,771,227.319,360,994,902.71
公告日期2023-10-312023-08-262023-04-292023-04-29
审计意见(境内)标准无保留意见
TOP↑